Prestige Consumer Overview
Prestige Consumer Healthcare is a focused OTC consumer healthcare company with brands across women's health, eye and ear care, gastrointestinal, dermatology, oral care, cough and cold, and household health. FY2026 revenue was $1.088705 billion, net income was $190.301 million, and Ronald M. Lombardi is President, CEO, and Chair of the Board.
How Prestige Consumer Makes Money
Prestige Consumer makes money by owning, marketing, and distributing over-the-counter healthcare brands through mass retailers, drug stores, grocery stores, e-commerce platforms, and international channels. The company relies heavily on third-party manufacturing, which keeps fixed assets light and makes brand management, retail execution, regulatory compliance, and supply reliability central to performance.
Prestige Consumer Financials
Prestige Consumer reported $1.088705 billion of FY2026 revenue, compared with $1.137762 billion in FY2025 and $1.125357 billion in FY2024. Net income was $190.301 million in FY2026, down from $214.605 million in FY2025, as organic revenue declined mainly from eye and ear care supply challenges.
Competitive Position
Prestige Consumer competes with Haleon, Bayer, Kenvue, Church & Dwight, Procter & Gamble, private labels, and category specialists. Larger rivals have more scale, but Prestige is more focused on smaller OTC categories where a trusted brand like Monistat, Clear Eyes, DenTek, Dramamine, or Fleet can hold shelf space and pricing power.
